Assaf Segal
Board Member
Elicio Therapeutics, Inc. (ELTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Assaf Segal
Assaf Segal is recorded as Board Member at Elicio Therapeutics, Inc. (ELTX). Elicio Therapeutics, Inc. reported in an 8-K filed August 30, 2023 that Assaf Segal resigned as Board of Directors, effective August 28, 2023. Elicio Therapeutics, Inc. reported in an 8-K filed June 2, 2023 that Assaf Segal was appointed Class II Director, effective June 1, 2023.
“On August 28, 2023, Assaf Segal submitted his resignation from the Board of Directors (the "Board") of Elicio Therapeutics, Inc. (the "Company"), which resignation was effective immediately.”
“Robert R. Ruffolo, Jr., PhD, FCPP, Assaf Segal and Karen J. Wilson being appointed as Class II directors of the Company whose terms expire at the Company's 2025 annual meeting of stockholders”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-06-01–present
-
2023-06-01–2023-08-28
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Carol Ashe Board Member
- Jay R. Venkatesan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.